Ahead of the Bell: Alkermes rises on Vivitrol vote

Published September 18, 2010

Ahead of the Bell: Alkermes rises on Vivitrol vote
Shares of Alkermes climbed in premarket trading Friday after a government panel recommended approval of a second use for its addiction drug.
Read more on AP via Yahoo! Finance

Biotech Stocks: Crucell, Arena sharpest movers in drug sector
Crucell N.V. and Arena Pharmaceuticals were the sharpest movers among the drug stock issues Friday afternoon.
Read more on Market Watch

Ahead of the Bell: Alkermes rises on Vivitrol vote
Shares of Alkermes climbed in premarket trading Friday after a government panel recommended approval of a second use for its addiction drug. Alkermes – United States – Vivitrol – Health – Substance abuse
Read more on Boston Globe